このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Elos Medtech 将来の成長

Future 基準チェック /06

現在、 Elos Medtechの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長	25.1%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Elos Medtech は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

OM:ELOS B - アナリストの将来予測と過去の財務データ ( )SEK Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
9/30/2023	1,018	55	-52	95	N/A
6/30/2023	998	55	-1	121	N/A
3/31/2023	961	76	-7	113	N/A
12/31/2022	889	75	-9	108	N/A
9/30/2022	843	94	7	123	N/A
6/30/2022	799	90	-17	81	N/A
3/31/2022	747	79	11	89	N/A
12/31/2021	724	76	19	105	N/A
9/30/2021	694	67	14	96	N/A
6/30/2021	655	62	45	125	N/A
3/31/2021	592	51	55	141	N/A
12/31/2020	580	36	69	126	N/A
9/30/2020	584	33	74	116	N/A
6/30/2020	593	29	43	105	N/A
3/31/2020	658	29	20	102	N/A
12/31/2019	689	39	4	102	N/A
9/30/2019	700	35	-4	107	N/A
6/30/2019	697	32	-12	95	N/A
3/31/2019	679	29	-21	67	N/A
12/31/2018	645	21	-14	66	N/A
9/30/2018	625	24	-12	66	N/A
6/30/2018	603	21	0	58	N/A
3/31/2018	593	23	12	59	N/A
12/31/2017	578	23	25	62	N/A
9/30/2017	562	18	40	68	N/A
6/30/2017	556	23	N/A	86	N/A
3/31/2017	552	29	N/A	90	N/A
12/31/2016	552	26	N/A	98	N/A
9/30/2016	555	27	N/A	95	N/A
6/30/2016	551	20	N/A	74	N/A
3/31/2016	539	15	N/A	71	N/A
12/31/2015	504	16	N/A	63	N/A
9/30/2015	474	17	N/A	120	N/A
6/30/2015	436	23	N/A	181	N/A
3/31/2015	398	26	N/A	196	N/A
12/31/2014	381	23	N/A	175	N/A
9/30/2014	371	25	N/A	120	N/A
6/30/2014	369	18	N/A	94	N/A
3/31/2014	366	17	N/A	75	N/A
12/31/2013	368	17	N/A	80	N/A
9/30/2013	396	20	N/A	82	N/A
6/30/2013	413	18	N/A	51	N/A
3/31/2013	424	12	N/A	46	N/A
12/31/2012	434	8	N/A	39	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ELOS Bの予測収益成長が貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: ELOS Bの収益がSwedish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: ELOS Bの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: ELOS Bの収益がSwedish市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: ELOS Bの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ELOS Bの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Elos Medtech 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Elos Medtech AB (publ) (OM:ELOS B) acquired Klingel Holding GmbH from IK Partners and Management.

Nasdaq Stockholm Approves Elos Medtech's Application for De-Listing

Elos Medtech Applies for De-Listing from Nasdaq Stockholm

New major risk - Shareholder dilution

Elos Medtech AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

Third quarter 2023 earnings released

Elos Medtech AB (publ) (OM:ELOS B) entered an agreement to acquire KLINGEL medical metal GmbH from IK Partners and Management for an enterprise value of €370 million.

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Investor sentiment improves as stock rises 20%

Elos Medtech AB (Publ) Elects Winfried Schaller as Board Member

First quarter 2023 earnings released

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr9.31 (vs kr9.37 in FY 2021)

No independent directors

Elos Medtech AB (publ) to Report Q3, 2023 Results on Oct 19, 2023

Third quarter 2022 earnings released

Elos Medtech AB Announces Nomination Committee Appointments

Elos Medtech AB (Publ) Announces Management Changes

Elos Medtech AB (Publ) Announces Management Changes

Second quarter 2022 earnings released

Elos Medtech AB (publ) Omits Dividend for the Year 2021

First quarter 2022 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Elos Medtech AB (publ)(OM:ELOS B) dropped from OMX Nordic Small Cap Index

Chief Financial Officer recently sold kr159k worth of stock

Chief Financial Officer recently sold kr159k worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Independent Director recently sold kr848k worth of stock

Second quarter 2021 earnings released: EPS kr2.28 (vs kr0.85 in 2Q 2020)

TA Associates Management, L.P. through its funds Ta Xiii-B, L.P., Ta Xiii-A, L.P. and TA Investors XIII, L.P. made an offer to acquire Elos Medtech AB (publ) (OM:ELOS B) from a group of sellers for SEK 1.7 billion.

Elos Medtech in Talks of Possible Takeover Bid

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

President & CEO recently sold kr801k worth of stock

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

New 90-day high: kr121

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

President & CEO recently bought kr233k worth of stock

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS kr4.46 (vs kr4.77 in FY 2019)

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

New 90-day high: kr117

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Elos Medtech AB (publ) Announces Executive Changes

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

New 90-day high: kr109

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

New 90-day high: kr98.80

Third-quarter earnings released: Revenue and earnings beat expectations

Third quarter earnings released

Elos Medtech AB (publ) to Report Q3, 2021 Results on Oct 20, 2021

New 90-day high - kr89.60

New 90-day high - kr77.20

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘